TSE
Trinseo PLC
Chemicals - Specialty
Market Cap$5M
5Y Perf.-99.4%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
TSE vs TROX vs EMN vs CC
Revenue, margins, valuation, and 5-year total return — side by side.
TROX
Tronox Holdings plc
Chemicals
Market Cap$1.34B
5Y Perf.+12.7%
EMN
Eastman Chemical Company
Chemicals - Specialty
Market Cap$8.43B
5Y Perf.+10.9%
CC
The Chemours Company
Chemicals - Specialty
Market Cap$3.36B
5Y Perf.+39.1%
TSE vs TROX vs EMN vs CC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | TSE | TROX | EMN | CC |
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $5M | $1.34B | $8.43B | $3.36B |
| Revenue (TTM) | $3.13B | $2.92B | $8.64B | $5.82B |
| Net Income (TTM) | $-412M | $-359M | $399M | $-411M |
| Gross Margin | 6.2% | 5.8% | 19.8% | 15.1% |
| Operating Margin | -4.3% | -4.8% | 9.4% | -0.8% |
| Forward P/E | — | — | 11.6x | 15.9x |
| Total Debt | $2.48B | $3.59B | $5.08B | $4.58B |
| Cash & Equiv. | $210M | $211M | $566M | $672M |
TSE vs TROX vs EMN vs CC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
TSE
TROX
EMN
CC
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Trinseo PLC (TSE) | 100 | 0.6 | -99.4% |
| Tronox Holdings plc (TROX) | 100 | 112.7 | +12.7% |
| Eastman Chemical Co… (EMN) | 100 | 110.9 | +10.9% |
| The Chemours Company (CC) | 100 | 139.1 | +39.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TSE vs TROX vs EMN vs CC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: EMN leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. The Chemours Company is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. TSE also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
TSE
Trinseo PLC
The Income Pick
TSE is the clearest fit if your priority is dividends.
- 38.5% yield, vs EMN's 4.5%
Best for: dividends
TROX
Tronox Holdings plc
The Income Angle
TROX lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: basic materials exposure
EMN
Eastman Chemical Company
The Income Pick
EMN carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 1.36, yield 4.5%
- Lower volatility, beta 1.36, Low D/E 84.1%, current ratio 1.37x
- Beta 1.36, yield 4.5%, current ratio 1.37x
- Lower P/E (11.6x vs 15.9x)
Best for: income & stability and sleep-well-at-night
CC
The Chemours Company
The Growth Play
CC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 0.4%, EPS growth -5.5%, 3Y rev CAGR -5.3%
- 219.7% 10Y total return vs TROX's 116.1%
- 0.4% revenue growth vs EMN's -6.7%
- +108.8% vs TSE's -96.9%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CC | 0.4% revenue growth vs EMN's -6.7% |
| Value | EMN | Lower P/E (11.6x vs 15.9x) |
| Quality / Margins | EMN | 4.6% margin vs TSE's -13.2% |
| Stability / Safety | EMN | Beta 1.36 vs TSE's 2.94 |
| Dividends | TSE | 38.5% yield, vs EMN's 4.5% |
| Momentum (1Y) | CC | +108.8% vs TSE's -96.9% |
| Efficiency (ROA) | EMN | 2.6% ROA vs TSE's -15.8%, ROIC 6.7% vs -2.0% |
TSE vs TROX vs EMN vs CC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
FY 2025
FY 2025
TSE vs TROX vs EMN vs CC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLEMNLAGGINGTROX
Who Leads Where
EMN leads in 4 of 6 categories
CC leads 1 • TSE leads 0 • TROX leads 0 • 1 tied
Explore the data ↓TROXTronox Holdings plc
0leads
TSETrinseo PLC
0leads
CCThe Chemours Company
1leads
EMNEastman Chemical Comp…
4leads
6 Total Categories
CATEGORYLEADERvs CCvs TSEMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
EMN4/6
Valuation MetricsMultiples, price ratios, and targets
EMN3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
EMN7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CC3/6
Risk & VolatilityBeta, volatility, and downside exposure
EMN2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
EMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 3.0x TROX's $2.9B. EMN is the more profitable business, keeping 4.6% of every revenue dollar as net income compared to TSE's -13.2%. On growth, TROX holds the edge at +3.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.1B | $2.9B | $8.6B | $5.8B |
| EBITDAEarnings before interest/tax | $88M | $166M | $1.2B | -$132M |
| Net IncomeAfter-tax profit | -$412M | -$359M | $399M | -$411M |
| Free Cash FlowCash after capex | -$96M | -$139M | $498M | $198M |
| Gross MarginGross profit ÷ Revenue | +6.2% | +5.8% | +19.8% | +15.1% |
| Operating MarginEBIT ÷ Revenue | -4.3% | -4.8% | +9.4% | -0.8% |
| Net MarginNet income ÷ Revenue | -13.2% | -12.3% | +4.6% | -7.1% |
| FCF MarginFCF ÷ Revenue | -3.1% | -4.8% | +5.8% | +3.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -14.3% | +3.0% | -4.9% | +1.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.5% | +7.1% | -40.8% | -6.1% |
EMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
EMN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than CC's 21.7x.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| Market CapShares × price | $5M | $1.3B | $8.4B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $4.7B | $12.9B | $7.3B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -2.83x | 17.97x | -8.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 11.63x | 15.86x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 5.59x | — |
| EV / EBITDAEnterprise value multiple | 13.84x | 16.80x | 8.96x | 21.72x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.46x | 0.96x | 0.58x |
| Price / BookPrice ÷ Book value/share | — | 0.92x | 1.41x | 13.44x |
| Price / FCFMarket cap ÷ FCF | — | — | 19.87x | 65.93x |
EMN leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
EMN leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-163 for CC. EMN carries lower financial leverage with a 0.84x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), TSE scores 5/9 vs TROX's 2/9, reflecting solid financial health.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -30.4% | +6.7% | -163.4% |
| ROA (TTM)Return on assets | -15.8% | -7.7% | +2.6% | -5.5% |
| ROICReturn on invested capital | -2.0% | -0.3% | +6.7% | -0.1% |
| ROCEReturn on capital employed | -2.1% | -0.4% | +7.5% | -0.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 5 | 4 |
| Debt / EquityFinancial leverage | — | 2.48x | 0.84x | 18.27x |
| Net DebtTotal debt minus cash | $2.3B | $3.4B | $4.5B | $3.9B |
| Cash & Equiv.Liquid assets | $210M | $211M | $566M | $672M |
| Total DebtShort + long-term debt | $2.5B | $3.6B | $5.1B | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | -0.43x | -1.16x | 2.22x | 1.15x |
EMN leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CC five years ago would be worth $7,726 today (with dividends reinvested), compared to $346 for TSE. Over the past 12 months, CC leads with a +108.8% total return vs TSE's -96.9%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs TSE's -76.4% — a key indicator of consistent wealth creation.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -80.6% | +98.1% | +15.8% | +83.6% |
| 1-Year ReturnPast 12 months | -96.9% | +76.9% | +2.3% | +108.8% |
| 3-Year ReturnCumulative with dividends | -98.7% | -23.6% | +3.4% | -15.7% |
| 5-Year ReturnCumulative with dividends | -96.5% | -55.1% | -28.4% | -22.7% |
| 10-Year ReturnCumulative with dividends | -79.8% | +116.1% | +35.4% | +219.7% |
| CAGR (3Y)Annualised 3-year return | -76.4% | -8.6% | +1.1% | -5.5% |
CC leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
EMN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EMN is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than TSE's 2.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EMN currently trades 87.5% from its 52-week high vs TSE's 2.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.15x | 2.38x | 1.32x | 1.81x |
| 52-Week HighHighest price in past year | $4.42 | $10.59 | $84.18 | $28.67 |
| 52-Week LowLowest price in past year | $0.06 | $2.86 | $56.11 | $9.13 |
| % of 52W HighCurrent price vs 52-week peak | +2.8% | +79.4% | +87.5% | +78.1% |
| RSI (14)Momentum oscillator 0–100 | 39.2 | 58.5 | 56.9 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 629K | 3.1M | 1.5M | 3.1M |
EMN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — TSE and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TROX as "Buy", EMN as "Buy", CC as "Hold". Consensus price targets imply 8.4% upside for EMN (target: $80) vs -10.8% for TROX (target: $8). For income investors, TSE offers the higher dividend yield at 38.53% vs CC's 2.31%.
| Metric | TSETrinseo PLC | TROXTronox Holdings p… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $7.50 | $79.89 | $24.14 |
| # AnalystsCovering analysts | — | 17 | 35 | 20 |
| Dividend YieldAnnual dividend ÷ price | +38.5% | +3.6% | +4.5% | +2.3% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 12 | 0 |
| Dividend / ShareAnnual DPS | $0.05 | $0.30 | $3.30 | $0.52 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.2% | 0.0% |
Evenly matched — TSE and EMN each lead in 1 of 2 comparable metrics.
Key Takeaway
EMN leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CC leads in 1 (Total Returns). 1 tied.
Best OverallEastman Chemical Company (EMN)Leads 4 of 6 categories
Loading custom metrics...
TSE vs TROX vs EMN vs CC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TSE or TROX or EMN or CC a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Tronox Holdings plc (TROX) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TSE or TROX or EMN or CC?
On forward P/E, Eastman Chemical Company is actually cheaper at 11.
6x.
03Which is the better long-term investment — TSE or TROX or EMN or CC?
Over the past 5 years, The Chemours Company (CC) delivered a total return of -22.
7%, compared to -96. 5% for Trinseo PLC (TSE). Over 10 years, the gap is even starker: CC returned +226. 5% versus TSE's -79. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TSE or TROX or EMN or CC?
By beta (market sensitivity over 5 years), Eastman Chemical Company (EMN) is the lower-risk stock at 1.
32β versus Trinseo PLC's 3. 15β — meaning TSE is approximately 138% more volatile than EMN relative to the S&P 500. On balance sheet safety, Eastman Chemical Company (EMN) carries a lower debt/equity ratio of 84% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
05Which is growing faster — TSE or TROX or EMN or CC?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Trinseo PLC grew EPS 50. 3% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, CC leads at -5. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TSE or TROX or EMN or CC?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 3% for TSE. At the gross margin level — before operating expenses — EMN leads at 21. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TSE or TROX or EMN or CC more undervalued right now?
On forward earnings alone, Eastman Chemical Company (EMN) trades at 11.
6x forward P/E versus 15. 9x for The Chemours Company — 4. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMN: 8. 4% to $79. 89.
08Which pays a better dividend — TSE or TROX or EMN or CC?
All stocks in this comparison pay dividends.
Trinseo PLC (TSE) offers the highest yield at 38. 5%, versus 2. 3% for The Chemours Company (CC).
09Is TSE or TROX or EMN or CC better for a retirement portfolio?
For long-horizon retirement investors, Eastman Chemical Company (EMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield). Trinseo PLC (TSE) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMN: +35. 3%, TSE: -79. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TSE and TROX and EMN and CC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TSE is a small-cap income-oriented stock; TROX is a small-cap income-oriented stock; EMN is a small-cap deep-value stock; CC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(TSE: -14.3% · TROX: 3.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.